Cryptosporidiosis

• FDA approval · 2025-02-03
  FDA Approved: NITAZOXANIDE — Original Application (ANI Pharmaceuticals, Inc.)

  FDA approved ANI Pharmaceuticals' original application for nitazoxanide, a generic treatment for infections caused by Giardia lamblia and Cr…

• FDA approval · 2022-08-11
  FDA Approved: NITAZOXANIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for nitazoxanide submitted by Rising Pharma Holdings, Inc. (Nitazoxanide).

• FDA approval · 2020-11-27
  FDA Approved: NITAZOXANIDE — Original Application (Rising Pharma Holdings, Inc.)

  FDA approves the Original Application for a generic nitazoxanide product by Rising Pharma Holdings, Inc.